IMAGE

Fig. S5

ID
ZDB-IMAGE-151009-57
Source
Figures for Li-Villarreal et al., 2015
Image
Figure Caption

Fig. S5

WT embryos treated with cytoskeleton altering agents.

A. Phalloidin labeling of F-actin at 16-cell stage for WT, WT treated with DMSO, WT treated with 1µg/mL cytochalasinD, and WT treated with 3µg/mL cytochalasinD from activation.

B. Bright field images of WT in vitro fertilized embryos in egg water, DMSO, 5µg/mL cytochalasinD, 10µg/mL cytochalasinD, and 15µg/mL cytochalasinD from activation at 50mpf.

C. gsc transcripts revealed by WISH in WT embryos treated at 1 hpf with DMSO, 3µg/mL cytochalasinD, 0.01µg/mL nocodazole, and 5µM taxol at 8 hpf; dorsal view.

D. ntl and gsc transcripts revealed by WISH in WT embryos treated at 1 hpf with DMSO, 0.002µg/mL nocodazole, and 0.005µg/mL nocodazole; 6 hpf animal pole view.

Acknowledgments
This image is the copyrighted work of the attributed author or publisher, and ZFIN has permission only to display this image to its users. Additional permissions should be obtained from the applicable author or publisher of the image. Full text @ Development